Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently released a draft guidance in collaboration with the Office for Human Research Protections, outlining recommendations for including tissue biopsies in …
FDA Issues Draft Guidance on Tissue Biopsies in Clinical Trials Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has unveiled the Savara Early Access Program, a significant initiative aimed at providing molgramostim to patients suffering from autoimmune pulmonary alveolar proteinosis (aPAP). This …
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment Read More
MALVERN, PA — YPrime has launched its cutting-edge eCOA 7.0 SaaS platform, poised to transform the clinical trial industry. This launch reflects YPrime’s dedication to integrating advanced technology with user-centric …
YPrime Unveils Revolutionary eCOA 7.0 Platform Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) is taking significant steps to ensure that clinical trials better reflect the diversity of the population they aim to serve. …
FDA Unveils Draft Guidance to Boost Diversity in Clinical Trials Read More MALVERN, PA — YPrime has released a research report titled “Endocrinology Clinical Trials: Advancing Research with the Help of eCOA Technologies.” This report, derived from a survey of clinical trial …
YPrime’s New Report Highlights Role of eCOA Technologies in Endocrinology Clinical Trials Read More
BERWYN, PA — Mural Health has been awarded the title of “Most Innovative Start-up” at the 2024 Citeline Awards. Citeline, a leader in business intelligence for pharmaceutical and medtech markets, …
Mural Health Named ‘Most Innovative Start-up’ at 2024 Citeline Awards Read More MALVERN, PA — YPrime has unveiled its latest innovation, the Tender Swollen Joint Count (TSJC) assessment. This tool is designed to revolutionize the way disease activity affecting joints is measured …
YPrime Introduces Innovative Assessment Tool to Enhance Clinical Trials for Autoimmune Diseases Read More MALVERN, PA — In a groundbreaking survey released by YPrime, a leading provider of clinical trial software solutions, insights into the complexities of conducting oncology clinical trials have been brought …
YPrime Survey Reveals Key Challenges in Oncology Trials, eCOA as a Solution Read More
MALVERN, PA — YPrime, a leading provider of electronic clinical outcomes assessment (eCOA) platforms, has released the results of a comprehensive survey examining the experiences and perspectives of clinical stakeholders …
YPrime Unveils Key Insights into eCOA Adoption and Concerns in Clinical Research Read More
MALVERN, PA — In a strategic move that underscores its nearly two-decade legacy of innovation in the clinical trial space, YPrime this week announced a comprehensive brand evolution initiative. The …
YPrime Unveils Bold Brand Evolution, Aiming to Streamline and Accelerate Clinical Trials Read More